Business Context and Reporting Period
Company: Medical Transcription Billing, Corp. (Note: Metadata lists "Carecloud, Inc." but the filing text identifies the registrant as Medical Transcription Billing, Corp.)
Filing Type: Form 8-K (Current Report)
Date of Report: October 13, 2017
Event: Entry into a Material Definitive Agreement (Loan and Security Agreement).
Key Financial Metrics and Transaction Details
- Facility Size: $5,000,000 revolving line of credit secured from Silicon Valley Bank (SVB).
- Interest Rate: Prime rate plus 1.75% on outstanding portions.
- Fees: 1% annual fee payable at closing and each anniversary; 0.5% fee on unused availability.
- Equity Component: Issuance of a warrant to SVB exercisable for 125,000 shares of common stock.
- Collateral: Obligations secured by substantially all of the Company's assets.
- Debt Repayment: Proceeds will repay approximately $500,000 outstanding to Opus Bank, closing that facility.
- Use of Proceeds: Remaining funds allocated for growth and general working capital.
Note: This filing does not provide revenue, profit, cash flow, or margin data.
Material Changes
The Company has replaced its existing $500,000 revolving line of credit with Opus Bank with a significantly larger $5,000,000 facility with Silicon Valley Bank. This represents a material increase in available liquidity and a change in primary lending counterparties.
Outlook, Risks, and Contingencies
- Management Commentary: The new facility is intended to support company growth and working capital needs.
- Risks: The Company's obligations are secured by substantially all assets, creating a risk of asset seizure in the event of default.
- Contingencies: The filing includes standard disclaimers that representations and warranties in the loan documents may change and should not be relied upon as characterizations of the actual state of facts by third parties.
Investor Verification Checklist
- Verify the exact terms of the warrant issued to SVB (exercise price, expiration date) in Exhibit 10.2.
- Confirm the current Prime Rate to calculate the effective interest cost of the new facility.
- Review the full Loan and Security Agreement (Exhibit 10.1) for specific financial covenants and default triggers.
- Monitor the press release (Exhibit 99.1) for additional strategic context regarding the "growth" plans funded by this credit.